Masami Kohchi

Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent

Yoshiaki Isshiki, Yasunori Kohchi, Hitoshi Iikura et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 76 citations · Full text

Medicinal Chemistry, Medicine, Available Anticancer Agent +6

Synthesis and structure–activity relationships of novel fungal chitin synthase inhibitors

Kazunao Masubuchi, Mikio Taniguchi, Isao UMEDA et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 42 citations · Full text

Biosynthesis, Antifungal Agent, Biochemistry +6

Synthesis and structure–activity relationships of novel benzofuran farnesyltransferase inhibitors

Kohsuke Asoh, Masami Kohchi, Ikumi Hyoudoh et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 40 citations · Full text

Medicinal Chemistry, Medicine, Structure–activity Relationships +3

Discovery of [5-Amino-1-(2-methyl-3<i>H</i>-benzimidazol-5-yl)pyrazol-4-yl]-(1<i>H</i>-indol-2-yl)methanone (CH5183284/Debio 1347), An Orally Available and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor

Hirosato Ebiike, Naoki Taka, Masayuki Matsushita et al. · Journal of Medicinal Chemistry · 2016 · 37 citations · Full text

Drug Target, Chemoprevention Strategy, Human Growth +25

Synthesis and antifungal activities of novel 1,3-β-d-glucan synthase inhibitors. Part 1

Kazunao Masubuchi, Takehiro Okada, Masami Kohchi et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 19 citations · Full text